Alerts will be sent to your verified email
Verify Email
SANDUPHQ
|
Sandu Pharmaceutical
|
Goldline Pharma.
|
Roopa Industries
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.72 % | 18.23 % | 9.08 % |
|
5yr average Equity Multiplier
|
1.33 | 2.92 | 4.1 |
|
5yr Average Asset Turnover Ratio
|
1.23 | 1.04 | 1.14 |
|
5yr Avg Net Profit Margin
|
2.27 % | 6.35 % | 2.02 % |
|
Price to Book
|
0.95 | 0.0 | 2.1 |
|
P/E
|
25.8 | 10.08 | 451.37 |
|
5yr Avg Cash Conversion Cycle
|
48.49 Days | 160.68 Days | 73.02 Days |
|
Inventory Days
|
74.6 Days | 97.06 Days | 122.64 Days |
|
Days Receivable
|
26.14 Days | 132.15 Days | 32.27 Days |
|
Days Payable
|
72.73 Days | 67.16 Days | 105.51 Days |
|
5yr Average Interest Coverage Ratio
|
28.2 | 2.27 | 1.96 |
|
5yr Avg ROCE
|
5.33 % | 30.67 % | 17.56 % |
|
5yr Avg Operating Profit Margin
|
3.77 % | 16.99 % | 6.21 % |
|
5 yr average Debt to Equity
|
0.0 | 1.44 | 1.4 |
|
5yr CAGR Net Profit
|
0.39 % | 61.2 % | 23.04 % |
|
5yr Average Return on Assets
|
2.79 % | 6.66 % | 2.2 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
37.79 % | 57.29 % | 48.03 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.62 % | 57.29 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sandu Pharmaceutical
|
Goldline Pharma.
|
Roopa Industries
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|